Hepatitis can be a silent killer.
Chronic viral hepatitis is a major problem worldwide. Rapid access to diagnostics and treatment are urgently needed.
MSF’s treatment of hepatitis is aimed at groups that are often harder to treat; the people we care for are more from marginalised groups, such as those living with HIV and tuberculosis (TB), prisoners, people who use drugs and sex workers.
Figures about hepatitis and our response
Data and information from MSF and other iNGOs
354M+
people estimated to be living with hepatitis B or C
5,770
people started on hepatitis C treatment by MSF in 2022
~30K
people were vaccinated against hepatitis E in South Sudan by MSF in 2022
